Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Effects of Solriamfetol on Quality of Life Measures From a 12-Week Phase 3 Randomized Trial.

< BACK TO ARCHIVE


2020 Apr 30


Ann Am Thorac Soc


http://www.ncbi.nlm.nih.gov/pubmed/32353246?dopt=Abstract

Effects of Solriamfetol on Quality of Life Measures From a 12-Week Phase 3 Randomized Trial.

Authors

Effects of Solriamfetol on Quality of Life Measures From a 12-Week Phase 3 Randomized Trial.
Weaver TE, Drake CL, Benes H, Stern T, Maynard J, Thein SG, Andry JM, Hudson JD, Chen D, Carter LP, Bron M, Lee L, Black J, Bogan RK
Ann Am Thorac Soc. 2020 Apr 30.
PMID: 32353246.

Abstract

Excessive daytime sleepiness in patients with obstructive sleep apnea is associated with substantial burden of illness.
Read This Paper